Skip to main content
Equibles

VANGUARD CAPITAL MANAGEMENT LLC

Position in BIAF — bioAffinity Technologies, Inc.

CIK 2100119 MALVERN, PA
Back to BIAF Full portfolio

Position in BIAF

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$45,100
-$167,629 QoQ
Shares Held
3,703
0.0% QoQ
Ownership
0.686%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 20 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BIAF Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

VANGUARD CAPITAL MANAGEMENT LLC holds $41,671,289,157 across 39 Diagnostics & Research names. BIAF ranks #36 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 24,276,316 $12,171,173,789
2 DHR
Danaher Corp /De/
 41,377,076 $7,881,505,436
3 IDXX
Idexx Laboratories Inc /De
 5,152,213 $2,712,331,011
4 A
Agilent Technologies, Inc.
 18,449,861 $2,450,695,036
5 WAT
Waters Corp /De/
 6,415,552 $2,406,088,622
6 IQV
Iqvia Holdings Inc.
 10,905,053 $2,107,074,340
7 NTRA
Natera, Inc.
 6,228,216 $1,690,649,233
8 MTD
Mettler Toledo International Inc/
 1,319,636 $1,685,848,186

All Filings in BIAF

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $45,100 55,543
2026-03-31 $212,729 55,543